Doctor
Dr. Rafael  Rosell

Dr. Rafael Rosell

Address: Carrer de Sabino Arana, 5, 19, Barcelona, Catalunya, Spain

Gender: Male

Type of Professional: Oncologist

Associated Healthcare Provider: QS Dexeus University Hospital

Languages Spoken: English, Spanish

About the Doctor

Dr. Rosell is the Head of Services of the Dr. Rosell Oncology lnstitute of the Hospital Universitari Dexeus Grupo Quirónsalud. Dr. Rosell has  earned a high professional standing within the scientific community with his focus is on translational oncology of non-small celllung  cancer. He is also the author of over 500 scientific articles in renowned medical journals such as the New England Journal of Medicine,  Clinical Cancer Research, Oncogene, The Lancet Oncology, Journal of Clinical Oncology and many more. Also, Dr. Rosell has received  several awards in recognition of his extensive scientific contributions.

Dr. Rosell is a member of the Committee for the lnternational Association for the Study of Lung Cancer and the European Association for  Cancer Research. He is also an active member of the Educational Committee of the European Medical Oncology Society and of the  Medical Protocols Review committee of the European Organization for Research and Treatment of Cancer. He was also a member of the  Scientific Committee of the American Society of Clinical Oncology from 2002 to 2004. Dr. Rosell is the lnternational Editor of the  Clinical Lung Cancer Journal. He is also a member of the group of editors for the following scientific publications: Lung Cancer, Annals of  Oncology, American Journal of Cancer, The Oncologist and Medicina Clínica.

More Information

Research and teaching: No. of patents (in which he participated): Title: Molecular Biomarkers for Predicting Response to Tyrosine-kinase Inhibitors in Lung Cancer. Title: Method for the detection o EGFR mutations in blood samples. Title: Molecular biomarkers for predicting response to Tyrosine-kinase Inhibitors in lung cancer. Title: Methods and reagents for predicting clinical outcome and customizing chemotherapy in lung cancer patients. Title: BRCA-1 mRNA expression levels predict survival in breast cancer patients treated with neoadjuvant chemotherapy. Title: BRCA1 mRNA expression predicts survival in patients with bladder cancer treated with neoadjuvant cisplatin-based chemotherapy.

Inquire Now